Author: Dr. David Lowemann

WeightWatchers Adds Novo’s Obesity Drug to Program

WeightWatchers said Tuesday it would offer compounded form of Novo Nordisk’s popular obesity drug Wegovy as part of its weight-management programs, sending its shares up 13% in early trading. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he […]

Published on October 8, 2024

EPA Sets 10-Year Deadline to Replace Water Lead Pipes

A decade after the Flint, Michigan, water crisis raised alarms about the continuing dangers of lead in tap water, President Joe Biden is setting a 10-year deadline for cities across the nation to replace their lead pipes, finalizing an aggressive approach aimed at ensuring… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]

Published on October 8, 2024

Antidepressant ‘Black Box’ Suicide Warning Backfired

“Black Box” warnings added to antidepressants might have contributed to an increase in suicide attempts and deaths among young people, a new evidence review claims. The warnings say that antidepressants might be associated with suicidal thoughts and behaviors in children and… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on October 8, 2024